# OnCo record torqur (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/torqur/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "torqur" ;
  schema:name "Torqur"@en ;
  schema:alternateName "Torqur AG"@en, "TORQUR"@en ;
  schema:description "Torqur is a Swiss company developing bimiralisib, a drug that blocks the PI3K and mTOR growth signals, as a tablet for cancer and as a skin gel for actinic keratosis, a sun-damage skin condition that can turn into skin cancer."@en ;
  schema:url <https://onco.cc/companies/torqur/>, <https://www.torqur.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.torqur.com/>, <https://www.torqur.com/company>, <https://www.torqur.com/news/torqur-receives-european-commission-orphan-drug-designation-for-bimiralisib-in-thymic-epithelial-tumours>, <https://clinicaltrials.gov/study/NCT06319794> ;
  schema:addressCountry "CH" ;
  onco:cancers <https://onco.cc/cancers/thymic-epithelial/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:technologies <https://onco.cc/technologies/pi3k-akt-mtor-inhibitors/> ;
  onco:targets <https://onco.cc/targets/mtor/> .